MT1 vs MT2: How the Two Melanotan Research Peptides Differ in the Lab
Few research compounds attract as much loose talk as the melanotan peptides, yet the underlying chemistry is far more modest than the chatter suggests. These are laboratory molecules that originated in a university setting, and the plain record of what they are is more interesting than any online promise. Vive Peptides, a US-based supplier of research-grade peptides, lists them strictly as research materials. Its compounding takes place at a US-based lab that works to cGMP requirements, and its certificate library covered 25 peptides with 126 certificates as of October 2026.
This explainer compares MT1 and MT2 purely as research peptides: what each one is, how their structures differ, and what the public chemistry records show. Vive Peptides sells both compounds, like everything else in its catalog, strictly for laboratory and research use only, and none of it is approved for human consumption. Readers in medicine and nursing will recognize the habit of separating a reagent’s identity from any claim about people, and that habit guides everything below.
What separates MT1 from MT2 at the structural level?
The separation is structural: MT1 is a linear analog of alpha-melanocyte-stimulating hormone (alpha-MSH), whereas MT2 is a ring-closed heptapeptide analog of that same hormone. Melanotan I is a straight chain carrying norleucine at position 4 and D-phenylalanine at position 7, while Melanotan II folds part of its seven-residue sequence into a ring. Think of a peptide as a chain of amino acids. A linear chain has two free ends and can flex along its whole length; a ring restricts how the molecule can fold.
Chemists care because shape governs how a ligand meets its receptor. A ring-shaped analog and a straight-chain analog are different probes, so results obtained with one should not be assumed to carry over to the other. The table sets out the contrast as it is framed in research and in the PubChem entries covered further down.
| Feature | MT1 | MT2 |
|---|---|---|
| Structure | Linear alpha-MSH analog | Ring-closed heptapeptide analog of alpha-MSH |
| Sequence detail | Norleucine at position 4, D-phenylalanine at position 7 | Seven-residue sequence with part of it closed into a ring |
| Receptor framing | MC1R and related melanocortin receptors | Non-selective across melanocortin receptors |
| CAS registry number | 75921-69-6 | 121062-08-6 |
Where did the melanotan peptides originate?
They originated at the University of Arizona in the 1980s. In 1984, Mac E. Hadley, working with chemist Victor Hruby and his students, synthesized highly active analogs of alpha-MSH there. The logic of an analog is simple: retain the recognizable core of a natural signaling molecule, then modify it so that it becomes a separate experimental object that can be compared with the original. Melanotan I is the linear version and Melanotan II the ring-closed one.
That lineage accounts for the naming and for the lasting academic interest. It also explains why this family sits in a catalog of research reagents, alongside other tools for mapping receptor biology, rather than on a shelf of consumer goods. A university pedigree is a reason for curiosity, not a permission slip.
How does a research listing describe MT2?
It describes the material in plain bench terms, and the MT2 entry makes a useful working example. The Vive Peptides MT2 listing describes a 10 mg research vial of Melanotan 2 acetate, registered under CAS 121062-08-6. The material is a white to off-white freeze-dried powder, and its mechanism class is given as a non-selective melanocortin receptor agonist, which is laboratory shorthand and nothing more.
Selectivity is the informative part of that phrase. A probe framed around a single receptor and a probe that engages the whole family answer different questions. The term non-selective signals the second kind of tool: a molecule meant to engage several melanocortin receptors at once rather than one in isolation. MT1 is framed around MC1R and related receptors, so the two peptides give a research team a pair to compare side by side in the same assay.
What do registry numbers and receptor cloning reveal about the two peptides?
They show that MT1 and MT2 are two distinct, well-indexed chemical entities that engage one shared receptor family. PubChem, the open chemistry database run by the US National Center for Biotechnology Information (NCBI), indexes these research peptides under the same CAS registry numbers the product pages give: 75921-69-6 for Melanotan 1 and 121062-08-6 for melanotan II. A registry number works as an identity tag for a molecule, so two different numbers confirm two separate compounds rather than one product sold under two names.
The receptor side has its own landmark. The genes for the melanocortin receptors, including MC1R, were cloned and reported in Science in 1992 by Kathleen Mountjoy, Lisa Robbins, Mark Mortrud and Roger Cone. MC1R signaling steers melanocytes toward eumelanin, the dark pigment, rather than pheomelanin, the red-yellow one, and the receptor recurs in pigmentation research in cell culture and animal models. Statements like these describe what a laboratory does with a reagent. They say nothing about what any compound might do in a person, and this article will not suggest otherwise.
At the bench, the comparison reduces to four points:
- MT1: linear structure, indexed under CAS 75921-69-6.
- MT2: ring-closed structure, indexed under CAS 121062-08-6.
- Shared target family: melanocortin receptors, with MC1R as the member followed here.
- Shared status at the supplier: strictly for laboratory and research use only.
Why are these peptides sold strictly for laboratory use?
Because they are research reagents rather than approved consumer products, and the label should say so plainly. The supplier sells these peptides strictly for laboratory and research use only, not for human consumption or veterinary use. Every product page carries a Research Use Only notice stating that the items are not approved for human consumption and that nothing on the page is medical advice. That label does real work: it tells a reader what the item is, what it is meant for, and what it is not.
A word about online hype belongs here too. The internet is full of confident claims about melanocortin peptides: forum threads, social clips, anonymous posts, secondhand stories. Almost none of it comes from controlled research, and none of it comes with accountability. A research label is not a loophole, and a stranger’s anecdote is not evidence. Unregulated personal use of laboratory chemicals carries unknown risks, and this article deliberately gives no usage details, because none belong in a piece about research materials. Anyone curious about their own body or appearance should talk with a licensed clinician and rely on products that are actually approved for the purpose, not on reagents made for the bench.
What should a reader take from the MT1 and MT2 comparison?
MT1 and MT2 are alpha-MSH analogs from a University of Arizona research tradition, one linear and one ring-closed, used by laboratories to examine melanocortin receptors in cell and animal models. The public record supports the distinction: PubChem indexes each under its own CAS number, and the receptor family they probe was cloned and reported in Science in 1992. Both are listed strictly for laboratory and research use only, and that frame is the one worth keeping. Appreciate the chemistry, discount the hype, and leave laboratory reagents in the laboratory.
